Antibiotic Resistance: Natural Selection in Real Time
Students analyze bacterial population data to explain how antibiotic use creates selection pressures and evaluate evidence-based strategies for slowing the spread of resistance.
Illustrations are auto-generated and may be placeholders. They can be refreshed to match the narration.
Variation in Bacterial Populations
Bacteria in the same population are not genetically identical. Random mutations can change genes involved in drug targets, cell membranes, or enzymes that break down antibiotics. Bacteria may also acquire resistance genes from other bacteria through horizontal gene transfer, often using small DNA molecules called plasmids. These variations arise before or independently of a particular antibiotic exposure; antibiotics do not create useful mutations because bacteria need them. For example, in a population of one million bacteria, a few cells might already carry a mutation that provides resistance to an antibiotic. Before treatment, resistant cells may be rare because resistance can require extra energy or reduce growth. The presence of heritable variation gives natural selection something to act upon when the environment changes.
Antibiotics as a Selection Pressure
An antibiotic creates a selection pressure by changing which bacteria are most likely to survive and reproduce. Susceptible bacteria die or stop reproducing, while bacteria with effective resistance traits have a survival advantage. The antibiotic does not cause individual bacteria to adapt intentionally. Instead, it changes the relative reproductive success of variants already present or newly produced by random mutation. Suppose a treatment kills 99.9 percent of a population of one million bacteria. About 1,000 survivors may remain, and resistant cells can make up a large fraction of them. As these survivors reproduce, they pass resistance genes to their descendants and may share genes with other bacteria. Unnecessary antibiotic use increases opportunities for this selection, while incorrect dosing can leave enough surviving bacteria to rebuild the population.
Interpreting Resistance Data
Resistance data are often presented in tables, line graphs, or hospital antibiograms that report the percentage of tested bacterial isolates classified as resistant. Students should connect the numerical values to the graph while checking sample size, units, and time period. For example, suppose a laboratory tests 200 isolates in 2018 and finds 10 resistant isolates, or 5 percent. In 2024, it tests 200 isolates and finds 70 resistant isolates, or 35 percent. A line graph would show a 30-percentage-point increase, while the number of resistant isolates increased sevenfold. These measures describe the sampled isolates, not necessarily every bacterium in the community. Changes in testing practices, patient populations, or sample sizes can affect the pattern, so a trend is strongest when methods remain consistent and multiple sources provide similar evidence.
Explaining Adaptation Across Generations
Natural selection produces adaptation at the population level across generations. Individual bacteria do not become resistant simply because they encounter an antibiotic. Instead, resistant bacteria leave more descendants under antibiotic exposure, so resistance alleles become more frequent. Imagine that resistant bacteria make up 1 percent of a starting population. After treatment removes most susceptible cells, resistant bacteria might represent 80 percent of the survivors. When those survivors reproduce by binary fission, their offspring inherit the resistance gene, causing the next population to contain a much higher resistance frequency. Plasmid transfer can spread resistance between bacterial lineages as well. If the antibiotic is removed, resistance may remain common, although a costly resistance trait may decline when susceptible bacteria reproduce faster. The evidence supports adaptation when heritable variation, differential survival, reproduction, and changing trait frequencies are all demonstrated.
Evaluating Antibiotic-Use Policies
Antibiotic-use policies should be evaluated by comparing intended benefits, supporting evidence, and possible unintended outcomes. Hospital stewardship programs may require diagnostic testing or approval before certain antibiotics are prescribed. Their intended outcomes are fewer unnecessary prescriptions, more targeted treatment, and slower resistance. However, complicated approval systems could delay urgent care unless exceptions are available. Policies limiting routine antibiotic use in livestock can reduce selection pressure and resistant bacteria entering communities, but farmers may face higher costs or animal-health challenges during the transition. Public reporting of resistance rates can improve accountability, although differences in testing may make facilities appear unfairly comparable. Strong policy packages combine surveillance, rapid diagnostics, vaccination, sanitation, patient education, and access to appropriate treatment. Decision-makers should track resistance rates, infection outcomes, costs, and equitable access, then revise policies when evidence reveals harms or weak results.
